Methylxanthines and human health: Epidemiological and experimental evidence

Handbook of Experimental Pharmacology

Volumn 200, Issue , 2011, Pages 509-548

  Beaudoin, Marie Soleil ^a   Graham, Terry E ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Adenosine; Caffeine; Cardiovascular disease; Coffee; Insulin resistance; Type 2 diabetes

Indexed keywords

CAFFEINE; CARBOHYDRATE; INSULIN; METHYLXANTHINE;

ADIPOSE TISSUE; ADRENAL MEDULLA; ADRENERGIC SYSTEM; ANTIOXIDANT ACTIVITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COFFEE; DIET SUPPLEMENTATION; FOOD INTAKE; GASTROINTESTINAL TRACT; GLUCOSE HOMEOSTASIS; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; INSULIN METABOLISM; LIVER PARENCHYMA; NEUROPROTECTION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ADRENAL MEDULLA; ANIMALS; CAFFEINE; CARDIOVASCULAR DISEASES; COFFEE; GASTROINTESTINAL TRACT; GLUCOSE; HOMEOSTASIS; HUMANS; LIVER; MUSCLE, SKELETAL;

EID: 77957592226     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-13443-2_21     Document Type: Review

References (194)

1. Acheson KJ, Zahorska-Markiewick B et al (1980) Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr 33(5):989-997
2. Acheson KJ, Gremaud G et al (2004) Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Am J Clin Nutr 79(1):40-46
3. Adeney KL, Williams MA et al (2007) Coffee consumption and the risk of gestational diabetes mellitus. Acta Obstet Gynecol Scand 86(2):161-166, Abstract
4. Agardh EE, Carlsson S et al (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255(6):645-652
5. Ahmed HN, Levitan E et al (2009) Coffee consumption and risk of heart failure in men: an analysis from the cohort of Swedish men. Am Heart J 158:667-672
6. Andrade-Cetto A, Wiedenfeld H (2001) Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats. J Ethnopharmacol 78 (2-3): 145-149
7. Antoniade C, Antonopoulos AS et al (2009) Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J 30(1):6-15
8. Arciero PJ, Gardner AW et al (1995) Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol 268 (6 Pt 1): E1192-E1198
9. Arion WJ, Canfield WK et al (1997) Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase. Arch Biochem Biophys 339(2):315-322
10. Ascherio A, Zhang SM et al (2001) Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol 50(1):56-63
11. Ascherio A, Chen H et al (2003) Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology 60(5):790-795 (Pubitemid 36297362)
12. Astrup A, Toubro S et al (1990) Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr 51(5):759-767
13. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132(6):2131-2157
14. Baker JA, Beehler GP (2006) Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. J Nutr 136(1):166-171
15. Barranco Quintana JL, Allam MF et al (2007) Alzheimer's disease and coffee: a quantitative review. Neurol Res 29(1):91-95
16. Battram DS, Graham TE et al (2005) The effect of caffeine on glucose kinetics in humans - influence of adrenaline. J Physiol 569(1):347-355
17. Battram DS, Arthur R et al (2006) The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J Nutr 136(5):1276-1280
18. Battram DS, Graham TE et al (2007a) Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline in humans. J Physiol 583(3):1069-1077
19. Battram DS, Bugaresti J et al (2007b) Acute caffeine ingestion does not impair glucose tolerance in persons with tetraplegia. J Appl Physiol 102(1):374-381
20. Belfort R, Mandarino L (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54(6):1640-1648
21. Bidel S, Hu G et al (2006) Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 49:2618-2626 (Pubitemid 44559523)
22. Boden G, Lebed B et al (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50(7):1612-1617
23. Bonen A, Megeney LA et al (1992) Epinephrine administration stimulates GLUT4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 187(2):685-691
24. Bracco D, Ferrarra JM et al (1995) Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 269 (4 Pt 1): E671-E678
25. Bravi F, Bosetti C et al (2007) Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 46(2):430-435
26. Bullock BP, Heller RS et al (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137(7):2968-2978
27. Buxton DB, Fisher RA et al (1987) Stimulation of glycogenolysis and vasoconstriction by adenosine analogs in the perfused rat liver. Biochem J 248:35-41
28. Camargo MC, Toledo MC et al (1999) Caffeine daily intake from dietary sources in Brazil. Food Addit Contam 16(2):79-87
29. Challis R A J, Budohoski L et al (1984) Effects of an adenosine-receptor antagonist on insulinresistance in soleus muscle from obese Zucker rats. Biochem J 221:915-917
30. Cheng JT, Chi TC et al (2000) Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats. Auton Neurosci 83:127-133
31. Cornelis MC, El-Sohemy A et al (2006) Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA 295(10):1135-1141
32. Daly JW, Fredholm BB (2004) Mechanisms of action of caffeine on the nervous system. In: Nehlig A (ed) Coffee, tea, chocolate and the brain, 1st edn. CRC Press, Boca Raton, FL
33. De Felice FG, Verira M N N et al (2009) Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of A beta oligomers. Proc Natl Acad Sci USA 106:1971-1976
34. de Galan BE, Tack CE et al (2002) Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes 51:790-796
35. Debrah K, Haigh R et al (1995) Effects of acute and chronic caffeine use on the cerebrovascular, cardiovascular and hormonal responses to orthostasis in healthy volunteers. Clin Sci (Lond) 89(5):475-480
36. Dekker MJ, Gusba JE et al (2007) Glucose homeostasis remains altered by acute caffeine ingestion following 2 weeks of daily caffeine consumption in previously non-caffeine-consuming males. Br J Nutr 98:556-562
37. Dixon AK, Gubitz AK et al (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118(6):1461-1468
38. Dresner A, Laurent D et al (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103(2):253-259
39. Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696-1705
40. Dulloo AG, Geissler CA et al (1989) Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr 49(1):44-50
41. Engler MB, Engler MM (2006) The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 64(3):109-118
42. Frary CD, Johnson RK, Wang MQ (2005) Food sources and intakes of caffeine in the diets of persons in the United States. J Am Diet Assoc 105(1):110-113
43. Fredholm BB, Bättig K et al (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51(1):83-133
44. Freedman ND, Everhart JE et al (2009) Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 50(5):1360-1369
45. Gallus S, Bertuzzi M et al (2002a) Does coffee protect against hepatocellular carcinoma? Br J Cancer 87:956-959 (Pubitemid 35305644)
46. Gallus S, Tavani A et al (2002b) Does coffee protect against liver cirrhosis? Ann Epidemiol 12(3):202-205 (Pubitemid 34189722)
47. Ganmaa D, Willett WC et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071-2076
48. Goodman MT, Tung KH et al (2003) Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 46(1):23-29
49. Graham TE, Spriet LL (1995) Metabolic, catecholamine, and exercise performance responses to various doses of caffeine. J Appl Physiol 78(3):867-874
50. Graham TE, Hibbert E et al (1998) Metabolic and exercise endurance effects of coffee and caffeine ingestion. J Appl Physiol 85(3):883-889
51. Graham TE, Helge JW et al (2000) Caffeine ingestion does not alter carbohydrate of fat metabolism in human skeletal muscle during exercise. J Physiol 529(3):837-847
52. Graham TE, Sathasivam P et al (2001) (2001) Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol 79:559-565
53. Greenberg JA, Axen KV et al (2005) Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes (Lond) 29(9):1121-1129
54. Greenberg JA, Owen DR et al (2009) Decaffeinated coffee and glucose metabolism in young men. Diabetes Care 33(2):278-280
55. Greer F, Hudson R et al (2001) Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes 50(10):2349-2354
56. Hallström H, Wolk A et al (2006) Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int 17:1055-1064
57. Hammar N, Andersson T et al (2003) Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study. J Intern Med 253:653-659
58. Han XX, Bonen A (1998) Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle. Am J Physiol 274 (4 Pt 1): E700-E707
59. Han DH, Hansen PA et al (1998) Removal of adenosine decreases the responsiveness of muscle glucose transport to insulin and contractions. Diabetes 47(11):1671-1675
60. Harris SS, Dawson-Hugues B (1994) Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr 60:573-578
61. Health Canada (2007) Caffeine. http://www.hc-sc.gc.ca/fn-an/securit/ facts-faits/caffeine-e.html. Cited 8 Feb. 2010.
62. Herling AW, Burger H et al (1999) Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. Eur J Pharmacol 368(1):75-82
63. Hernan MA, Takkouche B et al (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52(3):276-284
64. Hernandez-Avila M, Colditz GA et al (1991) Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women. Am J Clin Nutr 54:157-163
65. Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101-123
66. Hilliare-Buys D, Gross R et al (1989) Effect of pertussis toxin on A1 receptor-mediated inhibition of insulin secretion. Br J Pharmacol 96:3-4
67. Homko CJ, Cheung P et al (2003) Effects of free fatty acids on glucose uptake and utilization in healthy women. Diabetes 52(2):487-491
68. Honjo S, Kono S et al (2001) Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 54(8):823-829
69. Howlett K, Galbo H et al (1999) Effect of adrenaline on glucose kinetics during exercise in adrenalectomised humans. J Phys 519(3):911-921
70. Hu G, Bidel S et al (2007) Coffee and tea consumption and the risk of Parkinson's disease. Mov Disord 22(15):2242-2248
71. Hu G, Tuomilehto J et al (2008) Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 48(1):129-136
72. Huxley R, Lee C M Y et al (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus. Arch Intern Med 169(22):2053-2063
73. Ingelman-Sundberg M, Sim SC et al (2006) Coffee, myocardial infarction, and CYP nomenclature. JAMA 296(7):764-765
74. Inoue M, Yoshimi I et al (2005) Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 97:293-300
75. Inoue M, Kurahashi N et al (2009) Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomark Prev 18(6):1746-1753
76. Ishitani K, Lin J et al (2008) Caffeine consumption and risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168(18):2022-2031
77. Itani SI, Ruderman NB et al (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51(17):2005-2011
78. Jacobson TL, Febbraio MA et al (2001) Effect of caffeine co-ingested with carbohydrate or fat on metabolism and performance in endurance-trained men. Exp Physiol 86(1):137-144
79. Je Y, Liu W et al (2009) Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 124:1662-1668
80. Jee SH, He J et al (1999) The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension 33:647-652
81. Jee SH, He J et al (2001) Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol 153:353-362
82. Johansson SM, Yang JN et al (2007) Eliminating the antilipolytic adenosine A1 receptor does not lead to compensatory changes in the antilipolytic actions of PGE2 and nicotinic acid. Acta Physiol (Oxf) 190(1):87-96
83. Johnston KL, Clifford MN et al (2003) Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78(4):728-733
84. Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176(1):1-29
85. Jung RT, Shetty PS et al (1981) Caffeine: its effect on catecholamines and metabolism in lean and obese humans. Clin Sci (Lond) 60(5):527-535
86. Kabagambe EK, Wellons MF (2009) Benefits and risk of caffeine and caffeinated beverages. In Eamranond P (ed) UpToDate, version 17.3
87. Kacker S (2003) Ingestion of caffeinated coffee impairs blood glucose homeostasis in response to either high or low glycemic index cereals in non-obese males. Master thesis, University of Guelph
88. Keijzers GB, DeGalan BE et al (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25:364-369
89. Kiel DP, Felson DT et al (1990) Caffeine and the risk of hip fracture: the Framingham study. Am J Epidemiol 132:675-684
90. Kleemola P, Jousilahti P et al (2000) Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 160:3393-3400
91. Korpelainen R, Korpelainen J et al (2003) Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a population-based cohort study of 1222 women. Osteoporos Int 14(1):34-43
92. Kotsopoulos J, Ghadiria P et al (2007) The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomark Prev 16(5):912-916
93. Kruszynska YT, Worrall DS et al (2002) Fatty acid-induced insulin resistance: decreases muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab 87(1):226-234
94. Kurozawa Y, Ogimoto I et al (2005) Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 93:607-610
95. La Vecchia C, Tavani A (2007) Coffee and cancer risk: an update. Eur J Cancer Prev 16:385-389
96. Lane JD, Barkauskas CE et al (2004) Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 27(8):2047-2048
97. Lane JD, Feinglos MN et al (2008) Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes. Diabetes Care 31(2):221-222
98. Larsson SC, Bergkvist L et al (2006) Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol 163:638-644
99. Lee S, Hudson R et al (2005) Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28(3):566-572
100. Liang HX, Belardinelli L et al (2002) Tonic activity of the rat adipocyte A1-adenosine receptor. Br J Pharmacol 135(6):1457-1466
101. Lloyd T, Johnson-Rollings N et al (2000) Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation. J Am Coll Nutr 19(2):256-261
102. Lopez-Garcia E, van Dam RM et al (2006) Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr 83(3):674-680
103. Lopez-Garcia E, van Dam RM et al (2008) The relationship of coffee consumption with mortality. Ann Intern Med 148:904-914
104. Lopez-Garcia E, Rodriguez-Artalejo F et al (2009) Coffee consumption and risk of stroke in women. Circulation 119:1116-1123
105. Lovallo WR, Wilson MF et al (2004) Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension 43:760-765
106. Lundsberg LS (1998) Caffeine consumption. In: Spiller JA (ed) Caffeine, 1st edn. CRC Press, Boca Raton, FL
107. Lynge J, Hellsten Y (2000) Distribution of adenosine A1, A2a and A2b receptors in human skeletal muscle. Acta Physiol Scand 169:283-290
108. Maia L, de Mendonca A (2002) Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 9(4):377-382
109. Martin EA, Nicholson WT et al (2006a) Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia. J Appl Physiol 101(2):492-499
110. Martin EA, Nicholson WT et al (2006b) Influences of adenosine receptor antagonism on vasodilator responses to adenosine and exercise in adenosine responders and nonresponders. J Appl Physiol 101(6):1678-1684
111. Martin EA, Nicholson WT et al (2007) Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders. J Physiol 59 (Pt 1):237-245
112. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462-1470
113. McCarthy MF (2005) A chlorogenic acid-induced increase in GLP-1 production may mediate the impacts of heavy coffee consumption on diabetes risk. Med Hypotheses 64:848-853
114. McLane MP, Black PR et al (1990) Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes 39(1):62-69
115. McLean C, Graham TE (2002) Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women. J Appl Physiol 93:1471-1478
116. Meier JJ, Goetze O et al (2004) Gastric inhibitory polypeptide does not inhibit gastric emptying in humans. Am J Physiol Endocrinol Metab 286: E621-E625
117. Michels KB, Willet WC et al (2005) Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 97(4):282-292
118. Mineharu Y, Koizumi A et al (2009) Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health, doi:10.1136/jech.2009. 097311
119. Misra A, Khurana L (2008) Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 93: S9-S30
120. Mohr T, Van Soeren M et al (1998) Caffein ingestion and metabolic responses of tetraplegic humans during electrical cycling. J Appl Psysiol 85(3):979-985
121. Moisey LL, Kacker S et al (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87(5):1254-1261
122. Moisey LL, Robinson LE et al (2009) Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br J Nutr 103(6):833-841
123. Montella M, Polesel J et al (2007) Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Cancer 120(7):1555-1559 (Pubitemid 46355393)
124. Mukamal KJ, Hallqvist J et al (2009) Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 157:495-501
125. Naganuma T, Kuriyama S et al (2007) Coffee consumption and risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer 120:1542-1547 (Pubitemid 46355391)
126. Nawrot P, Jordan S et al (2003) Effects of caffeine on human health. Food Addit Contam 20(1):1-30
127. Nkondjock A, Ghadirian P et al (2006) Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Int J Cancer 118(1):103-107 (Pubitemid 41681585)
128. Norager CB, Jensen MB et al (2006) Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol 65:223-228
129. Nygard O, Refsum H et al (1997) Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 65:136-143
130. Olmos V, Bardoni N et al (2009) Caffeine levels in beverages from Argentina's market: application to caffeine dietary intake assessment. Food Addit Contam A Chem Anal Control Expos Risk Assess 26(3):275-281
131. Palatini P, Ceolotto G et al (2009) CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens 27(8):1594-1601
132. Pelluchi C, La Vecchia C (2009) Alcohol, coffee, and bladder cancer risk: a review of epidemiological studies. Eur J Cancer Prev 18(1):62-68
133. Pencek RR, Battram D et al (2004) Portal vein caffeine infusion enhances net hepatic glucose uptake during a glucose load in conscious dogs. J Nutr 134(11):3042-3046
134. Pereira MA, Parker ED et al (2006) Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 166(12):1311-1316
135. Petrie HJ, Chown SE et al (2004) Caffeine ingestion increases the insulin response to an oralglucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 80(1):22-28
136. Pizziol A, Tikhonoff V et al (1998) Effects of caffeine on glucose tolerance: a placebo-controlled study. Eur J Clin Nutr 52(11):846-849, Abstract
137. Quinlan PT, Lane J et al (2000) The acute physiological and mood effects of tea and coffee: the role of caffeine level. Pharmacol Biochem Behav 66(1):19-28
138. Ranheim T, Halvorsen B (2005) Coffee consumption and human health - beneficial or detrimental? Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Mol Nutr Food Res 49:274-284
139. Rapuri PB, Gallagher C et al (2001) Caffeine intake increases the rate of bone lose in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74:694-700
140. Reissig CJ, Strain ED et al (2009) Caffeinated energy drinks - a growing problem. Drug Alcohol Depend 99 (1-3): 1-10
141. Reppert SM, Weaver DR (1991) Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 5(8):1037-1048
142. Ricksen NP, Rongen GA et al (2009) Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther 121(2):185-191
143. Riksen NP, Smits P et al (2010) The cardiovascular effects of methylxanthines. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
144. Robinson LE, Spafford et al (2009) Acute caffeine-induced impairment in insulin sensitivity in women with gestational diabetes mellitus. J Obstet Gynacol Can 31:304-312
145. Robertson D, Wade D et al (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67(4):1111-1117
146. Robinson LE, Savani S et al (2004) Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 134(10):2528-2533
147. Rosner SA, Akesson A et al (2006) Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol 165:288-293
148. Ruhl CE, Everhart JE (2005a) Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 128(1):24-32
149. Ruhl CE, Everhart JE (2005b) Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129(6):1928-1936
150. Rush JW, Spriet LL (2001) Skeletal muscle glycogen phosphorylase a kinetics: effects of adenine nucleotides and caffeine. J Appl Physiol 91(5):2071-2078
151. Salazar-Martinez E, Willet WC et al (2004) Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140(1):1-8
152. Sandhu H, Wiesenthal SR et al (1999) Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. Diabetes 48(5):1045-1053
153. Sasaki H, Takaoka I et al (1987) Effects of sucrose or caffeine ingestion on running performance and biochemical responses to endurance running. Int J Sports Med 8(3):203-207 (Pubitemid 17112535)
154. Sawynok J (2010) Methylxanthines and pain. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
155. Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15(9):813-827
156. Shearer J, Farah A et al (2003) Quinides of roasted coffee enhance insulin action in conscious rats. J Nutr 133(11):3529-3532
157. Shearer J, Sellars EA et al (2007) Effects of chronic coffee consumption on glucose kinetics in the conscious rat. Can J Physiol Pharmacol 85:823-830
158. Shimazu T, Tsuborno Y et al (2005) Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 116(1):150-154
159. Silletta MG, Marfisi RM et al (2007) Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSS (Gruppo italiano per lo studio della sopravvievenza nell'infarto miocardico) - prevenzione trial. Circulation 116:2944-2951
160. Smith B, Wingard DL et al (2006) Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose? Diabetes Care 29:2385-2390
161. Smits P, Hoffmann H et al (1983) Hemodynamic and humoral effects of coffee after beta 1-selective and nonselective beta-blockade. Clin Pharmacol Ther 34(2):153-158 (Pubitemid 13042997)
162. Smits P, Lenders JW et al (1990) Caffeine and theophylline attenuate adenosine-induced vasodilation in humans. Clin Pharmacol Ther 48(4):410-418
163. Smits P, Stratman C et al (1991) Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther 50 (5 Pt 1):529-537
164. Stamler J, Vaccaro O et al (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16(2):434-444
165. Tan EK, Tan C et al (2003) Dose-dependent protective effects of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci 216(1):163-167
166. Tanaka K, Hara M et al (2007) Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Cancer Sci 98(2):214-218
167. Thom E (2007) The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J Int Med Res 35:900-908
168. Thong F S L, Graham TE (2002) Caffeine-induced impairment of glucose tolerance is abolished by beta-adrenergic receptor blockade in humans. J Appl Physiol 92(6):2347-2352
169. Thong F S L, Derave W et al (2002) Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes 51(3):583-590
170. Thong FS, Lally JS et al (2007) Activation of the A1 adenosine receptor increases insulinstimulated glucose transport in isolated rat soleus muscle. Appl Physiol Nutr Metab 32(4):701-710
171. + uptake. Cell Biochem Funct 26:833-843
172. Tse S Y H (1991) Coffee contains cholinomimetic compound distinct from caffeine. 1: purification and chromatographic analysis. J Pharm Sci 80:665-669
173. Tse S Y H (1992) Cholinomimetic compound distinct from caffeine contained in coffee. II: Muscarinic actions. J Pharm Sci 81:449-452
174. Tunicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33:1290-1300
175. Tunicliffe JM, Erdman KA et al (2008) Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl Physiol Nutr Metab 33:1301-1310
176. Tuomilehto J, Hu G et al (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291(10):1213-1219
177. van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular disease, and cancer. Appl Physiol Nutr Metab 33:1269-1283
178. van Dam RM, Hu FB (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294(1):97-104
179. van Dam RM, Willett WC et al (2006) Coffee, caffeine, and risk of type 2 diabetes. Diabetes Care 29(2):398-403
180. van Dijk AE, Olthof MR et al (2009) Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 32:1023-1025
181. Van Dusseldorp M, Katan MB et al (1991) Cholesterol-raising factor from boiled coffee does not pass a paper filter. Arterioscler Thromb Vasc Biol 11:586-593
182. Van Nieuwenhoven MA, Brummer RM et al (2000) Gastrointestinal function during exercise: comparison of water, sports drink, and sports drink with caffeine. J Appl Physiol 89(3):1079-1085
183. Van Soeren MH, Nohr T et al (1996) Acute effects of caffeine ingestion at rest in humans with impaired epinephrine responses. J Appl Physiol 80:999-1005
184. Van Soeren MH, Sathasivam P et al (1993) Caffeine metabolism and epinephrine responses during exercise in users and nonusers. J Appl Physiol 75(2):805-812
185. Vergauwen L, Hespel P et al (1994) Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93:974-981
186. Vergauwen L, Richter EA et al (1997) Adenosine exerts a glycogen-sparing action in contracting rat skeletal muscle. Am J Physiol 272 (5 Pt 1): E762-E768
187. Villanueva CM, Silverman DT et al (2009) Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control 20(1):121-127
188. Wei Y, Mojsov S (1996) Distribution of GLP-1 and PACAP receptors in human tissues. Acta Physiol Scand 157(3):355-357
189. World Health Organization (2010) Diabetes. http://www.who.int/ mediacentre/factsheets/fs312/en/print.html. Accessed 10 Feb. 2010
190. Wu T, Willet WC et al (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U. S. women. Diabetes Care 28:1390-1396
191. Yamada M, Sasaki S et al (2009) Estimation of caffeine intake in Japanese adults using 16 d weighed diet records based on a food composition database newly developed for Japanese populations. Public Health Nutr 16:1-10
192. Yeo SE, Jentjens RL et al (2005) Caffeine increases exogenous carbohydrate oxidation during exercise. J Appl Physiol 99(3):844-850
193. Zeegers MP, Tan FE et al (2001) Are coffee and tea consumption associated with urinary tract cancer risk? Int J Epidemiol 30(2):353-362
194. Zhang WL, Lopez-Garcia E et al (2009) Coffee consumption and risk of cardiovascular events and all-cause mortality among women with type 2 diabetes. Diabetologia 52:810-817